Matinas BioPharma
MTNB
#9681
Rank
โ‚น39.26 M
Marketcap
โ‚น7.83
Share price
0.00%
Change (1 day)
-98.72%
Change (1 year)

Operating Margin for Matinas BioPharma (MTNB)

Operating Margin as of September 2024 (TTM): -479.17%

According to Matinas BioPharma's latest financial reports and stock price the company's current Operating Margin is -479.17%. At the end of 2022 the company had an Operating Margin of -771.33%.

Operating Margin history for Matinas BioPharma from 2017 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2022-771.33%-98.97%
2021-74,954.55%390.27%
2020-15,288.38%-27.43%
2019-21,067.38%72.25%
2018-12,230.94%10.94%
2017-11,024.61%
2015-5,096.04%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.